Cbl-b−/− mice have less exhausted T lymphocytes present in the tumor environment, and targeted depletion of Cbl-b, via CRISPR/Cas9, can restore the expression of inflammatory cytokines and cytotoxic molecules in wild-type exhausted PD1+Tim3+ T cells [131]. This evidence concerns the gene CBLB and neoplasm.